Assoc Clinic Of Musclskltl Disease is categorized under Sports Medicines in Harlingen, TX and active since 1994.
Assoc Clinic Of Musclskltl Disease was established in 1994, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Sports Medicines business, which does work in the B2C market, and is classified as a Sports Medicines, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Herman Keillor at the company’s single location by writing to 1801 North Ed Carey Drive, Harlingen, Texas TX 78550 or by phoning (956) 423-5033. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Assoc Clinic Of Musclskltl Disease |
| Contact Person: | Herman Keillor |
| Address: | 1801 North Ed Carey Drive, Harlingen, Texas 78550 |
| Phone Number: | (956) 423-5033 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Sports Medicines |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Assoc Clinic Of Musclskltl Disease was started in 1994 to provide professional Sports Medicines under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Herman Keillor for inquiries that concern Assoc Clinic Of Musclskltl Disease by calling the company number (956) 423-5033, as your correspondence is most welcome. Additionally, the physical location of the single location of Assoc Clinic Of Musclskltl Disease can be found at the coordinates 26.175318,-97.67233 as well as the street address 1801 North Ed Carey Drive in Harlingen, Texas 78550.
For its online presence, you may visit Assoc Clinic Of Musclskltl Disease’s website at and engage with its social media outlets through on Twitter and on Facebook.